Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Grant/Award of 2,987 GKOS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | GLAUKOS Corp (GKOS) | Grant/Award | 2,987 | n/a |
| Jan 8, 2026 | GLAUKOS Corp (GKOS) | Grant/Award | 1,168 | n/a |
| Jun 2, 2025 | GLAUKOS Corp (GKOS) | Grant/Award | 864 | n/a |
| Feb 28, 2025 | GLAUKOS Corp (GKOS) | Exercise/Conversion | 25,000 | $800.0K |
| Jul 2, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 1,000 | $2.2K |
| Jun 4, 2024 | GLAUKOS Corp (GKOS) | Grant/Award | 1,716 | n/a |
| Mar 19, 2024 | Revance Therapeutics, Inc. (RVNC) | Tax Withholding | 3,305 | $17.5K |
| Mar 8, 2024 | Revance Therapeutics, Inc. (RVNC) | Purchase | 30,000 | $209.4K |
| Mar 4, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 70,750 | n/a |
| Feb 27, 2024 | GLAUKOS Corp (GKOS) | Exercise/Conversion | 10,000 | $72.8K |